Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A review on potential of natural products in the management of COVID-19
Rudra Chakravarti, Rajveer Singh, Arijit Ghosh, et al.
RSC Advances (2021) Vol. 11, Iss. 27, pp. 16711-16735
Open Access | Times Cited: 79

Showing 1-25 of 79 citing articles:

Tomatidine and Patchouli Alcohol as Inhibitors of SARS-CoV-2 Enzymes (3CLpro, PLpro and NSP15) by Molecular Docking and Molecular Dynamics Simulations
Rafat Zrieq, Iqrar Ahmad, Mejdi Snoussi, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10693-10693
Open Access | Times Cited: 79
Commercially Available Flavonols Are Better SARS-CoV-2 Inhibitors than Isoflavone and Flavones
Otávio Augusto Chaves, Natália Fintelman-Rodrigues, Xuanting Wang, et al.
Viruses (2022) Vol. 14, Iss. 7, pp. 1458-1458
Open Access | Times Cited: 38
Potential RNA-dependent RNA polymerase (RdRp) inhibitors as prospective drug candidates for SARS-CoV-2
Mohamed S. Bekheit, Siva S. Panda, Adel S. Girgis
European Journal of Medicinal Chemistry (2023) Vol. 252, pp. 115292-115292
Open Access | Times Cited: 26
Green and efficient one-pot three-component synthesis of novel drug-like furo[2,3-d]pyrimidines as potential active site inhibitors and putative allosteric hotspots modulators of both SARS-CoV-2 MPro and PLPro
Hossein Mousavi, Behzad Zeynizadeh, Mehdi Rimaz
Bioorganic Chemistry (2023) Vol. 135, pp. 106390-106390
Open Access | Times Cited: 24
Discovery of procyanidin condensed tannins of (−)-epicatechin from Kratom, Mitragyna speciosa, as virucidal agents against SARS-CoV-2
Sanya Sureram, Nopporn Chutiwitoonchai, Tam Pooprasert, et al.
International Journal of Biological Macromolecules (2024) Vol. 273, pp. 133059-133059
Closed Access | Times Cited: 8
Targeting the receptor binding domain and heparan sulfate binding for antiviral drug development against SARS-CoV-2 variants
Zi-Sin Yang, Tzong-Shiun Li, Yu-Sung Huang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Natural Bioactive Molecules: An Alternative Approach to the Treatment and Control of COVID-19
Fahadul Islam, Shabana Bibi, Atkia Farzana Khan Meem, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 12638-12638
Open Access | Times Cited: 50
Coronavirus Infection-Associated Cell Death Signaling and Potential Therapeutic Targets
Rittibet Yapasert, Patompong Khaw-on, Ratana Banjerdpongchai
Molecules (2021) Vol. 26, Iss. 24, pp. 7459-7459
Open Access | Times Cited: 49
Antiviral activity of natural phenolic compounds in complex at an allosteric site of SARS-CoV-2 papain-like protease
Vasundara Srinivasan, H. Brognaro, Prince R. Prabhu, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 35
Advances in delivery methods of Arthrospira platensis (spirulina) for enhanced therapeutic outcomes
Omar Ashraf ElFar, Nashiru Billa, Hooi Ren Lim, et al.
Bioengineered (2022) Vol. 13, Iss. 6, pp. 14681-14718
Open Access | Times Cited: 33
TCM2COVID: A resource of anti‐COVID‐19 traditional Chinese medicine with effects and mechanisms
Liping Ren, Yi Xu, Lin Ning, et al.
iMeta (2022) Vol. 1, Iss. 4
Open Access | Times Cited: 27
Antibacterial, Antifungal, and Antiviral Bioactive Compounds from Natural Products
Xun Song
Molecules (2024) Vol. 29, Iss. 4, pp. 825-825
Open Access | Times Cited: 6
Pharmacologic Activities of Plant-Derived Natural Products on Respiratory Diseases and Inflammations
Deepak Timalsina, Krishna Prasad Pokhrel, Deepti Bhusal
BioMed Research International (2021) Vol. 2021, pp. 1-23
Open Access | Times Cited: 33
Systematic virtual screening in search of SARS CoV-2 inhibitors against spike glycoprotein: pharmacophore screening, molecular docking, ADMET analysis and MD simulations
Tejas M. Dhameliya, Prinsa R. Nagar, Normi D. Gajjar
Molecular Diversity (2022) Vol. 26, Iss. 5, pp. 2775-2792
Open Access | Times Cited: 25
Plastic Antibodies Mimicking the ACE2 Receptor for Selective Binding of SARS‐CoV‐2 Spike
Alex D. Batista, Soumya Rajpal, Benedikt Keitel, et al.
Advanced Materials Interfaces (2022) Vol. 9, Iss. 5
Open Access | Times Cited: 22
Pharmacotherapeutic Potential of Natural Products to Target the SARS-CoV-2 PLpro Using Molecular Screening and Simulation Approaches
Abrar Mohammad Sayaf, Hassaan Ahmad, Muhammad Ammar Aslam, et al.
Applied Biochemistry and Biotechnology (2023) Vol. 195, Iss. 11, pp. 6959-6978
Open Access | Times Cited: 15
Anti-SARS-CoV-2 Activity and Cytotoxicity of Amaryllidaceae Alkaloids from Hymenocallis littoralis
Ngoc-Thao-Hien Le, Steven De Jonghe, Kristien Erven, et al.
Molecules (2023) Vol. 28, Iss. 7, pp. 3222-3222
Open Access | Times Cited: 13
β-Carboline alkaloids induce structural plasticity and inhibition of SARS-CoV-2 nsp3 macrodomain more potently than remdesivir metabolite GS-441524: computational approach
Yusuf Oloruntoyin Ayipo, Yahaya Sani Najib, Halimah Funmilayo Babamale, et al.
TURKISH JOURNAL OF BIOLOGY (2021) Vol. 45, Iss. SI-1, pp. 503-517
Open Access | Times Cited: 24
Molecular Mechanisms of Possible Action of Phenolic Compounds in COVID-19 Protection and Prevention
Nikola Gligorijević, Mirjana Radomirović, Olgica Nedić, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 22, pp. 12385-12385
Open Access | Times Cited: 24
Invalidation of dieckol and 1,2,3,4,6-pentagalloylglucose (PGG) as SARS-CoV-2 main protease inhibitors and the discovery of PGG as a papain-like protease inhibitor
Haozhou Tan, Chunlong Ma, Jun Wang
Medicinal Chemistry Research (2022) Vol. 31, Iss. 7, pp. 1147-1153
Open Access | Times Cited: 16
In‐silico Computational Investigations of AntiViral Lignan Derivatives as Potent Inhibitors of SARS CoV‐2
Dipen K. Sureja, Ashish Shah, Normi D. Gajjar, et al.
ChemistrySelect (2022) Vol. 7, Iss. 28
Open Access | Times Cited: 15
Plant Metabolites as SARS-CoV-2 Inhibitors Candidates: In Silico and In Vitro Studies
Alberto Jorge Oliveira Lopes, Gustavo Pereira Calado, Yuri Nascimento Fróes, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 9, pp. 1045-1045
Open Access | Times Cited: 15
A Short Review on Glucogallin and its Pharmacological Activities
Dipanjan Ghosh, Anam Najib Khan, Rajveer Singh, et al.
Mini-Reviews in Medicinal Chemistry (2022) Vol. 22, Iss. 22, pp. 2820-2830
Closed Access | Times Cited: 14
Integrated molecular and quantum mechanical approach to identify novel potent natural bioactive compound against 2′-O-methyltransferase (nsp16) of SARS-CoV-2
Jobin Thomas, Sanjit Kumar, Jitendra Satija
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 4, pp. 1999-2012
Closed Access | Times Cited: 8
A mini-review of the anti-SARS-CoV-2 potency of Amaryllidaceae alkaloids
Ngoc-Thao-Hien Le, Kerrin Janssen, Johannes Kirchmair, et al.
Phytomedicine (2024) Vol. 129, pp. 155576-155576
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top